Alzheimer's vs. vascular dementia vs. Lewy body vs. frontotemporal dementia: what families need to know

When a parent is diagnosed with dementia, the conversation often moves quickly. There's a word — "dementia" — and then a follow-up appointment, a pamphlet, maybe a referral. What can get lost in that moment is that "dementia" is not a single disease. It is a broad term for a category of conditions, each with a different cause, a different progression pattern, and — critically — different implications for care.

This matters in a very practical way. The type of dementia your parent has affects which medications are safe (and which can be dangerous), how the disease is likely to progress, what daily support will look like, and what your care team should be monitoring. Families who understand the distinction don't just know more — they're better positioned to ask the right questions, advocate at the right moments, and plan with more accuracy.

This article is not about diagnosing. It's about helping you translate what the neurologist told you into something usable — so the next appointment is a real conversation, not a one-way report.

---

Why "dementia" as a catch-all is misleading

The word dementia describes a set of symptoms: significant decline in memory, thinking, and daily functioning that is serious enough to interfere with life. It is not a diagnosis on its own, in the same way "joint pain" is not a diagnosis. Arthritis, a stress fracture, and an autoimmune condition all cause joint pain and each requires a completely different treatment approach.

The four most common types of dementia each have a different underlying cause:

• Alzheimer's disease is caused by the accumulation of amyloid plaques and tau tangles that damage neurons over time
• Vascular dementia results from reduced blood flow to the brain, usually from small strokes or chronic vessel disease
• Lewy body dementia is caused by abnormal protein deposits (Lewy bodies) that disrupt brain function and are also present in Parkinson's disease
• Frontotemporal dementia (FTD) involves the degeneration of the frontal and temporal lobes, which govern personality, behavior, and language

Each one looks different, progresses differently, and requires a different care approach. Getting the specific diagnosis — not just the umbrella term — is worth the effort.

---

Alzheimer's disease

What it is and how it progresses

Alzheimer's is the most common form of dementia, accounting for roughly 60–80% of cases. It typically begins with short-term memory loss — difficulty recalling recent conversations, misplacing items, repeating questions — before slowly affecting other cognitive functions like language, spatial reasoning, and eventually basic daily tasks.

The progression is gradual and roughly continuous. Most people live 8–10 years after diagnosis, though this varies widely. Early and middle stages are often characterized by memory and navigational difficulties; later stages involve loss of language, mobility, and the ability to perform basic self-care.

What's different about care

Care for Alzheimer's tends to be organized around memory support and safety over time. Early on, this often means structured routines, medication management support, and reducing decision fatigue. As the disease progresses, the focus shifts toward preventing wandering, maintaining dignity in personal care, and eventually supporting swallowing and mobility.

Familiar environments and consistent routines matter significantly for Alzheimer's. Changes — a new caregiver, a move, even a different room layout — can trigger confusion and distress in ways that may not be obvious in other conditions.

Memory care facilities are largely designed with Alzheimer's progression in mind, which makes them a reasonable fit for many families, though it's worth asking whether staff are trained for the specific stage your parent is in.

Questions to ask the neurologist

• What stage is the Alzheimer's at currently, and what does typical progression look like from here?
• Are there any medications (cholinesterase inhibitors like donepezil, or lecanemab/donanemab if eligible) that are appropriate to discuss?
• What safety concerns should we be planning for now, even if they're not present yet — wandering, driving, falls?
• What early support structures tend to make the biggest difference at this stage?

---

Vascular dementia

What it is and how it progresses

Vascular dementia is the second most common type, and its cause is distinctly different from Alzheimer's: it results from impaired blood flow to the brain. This can happen after a major stroke, but more commonly it develops from a series of small, sometimes silent strokes (called transient ischemic attacks or lacunar infarcts) or from chronic damage to small blood vessels.

The hallmark of vascular dementia is a stepped progression rather than the gradual slope of Alzheimer's. A person may plateau for months, then decline noticeably after another vascular event, then stabilize again. This is different from the slow, steady decline of Alzheimer's and is important for families to understand so they don't misread a stable period as recovery.

What's different about care

Because vascular dementia is driven by cardiovascular risk, managing those risk factors is one of the most actionable things the care team can do. Blood pressure control, blood sugar management for diabetics, cholesterol treatment, and antiplatelet medications (like aspirin or clopidogrel, if appropriate) may all help slow the progression of vascular damage. This is different from Alzheimer's, where there is no intervention that directly slows the underlying pathology for most patients.

The cognitive profile can also be different. Some people with vascular dementia have relatively preserved memory but significant difficulties with processing speed, attention, and executive function — planning, organizing, and following multi-step tasks. That pattern can look different from Alzheimer's to family members who are expecting memory loss to be the central feature.

Questions to ask the neurologist

• Which cardiovascular risk factors should we be most focused on controlling?
• Is the pattern stepped or gradual, and what does the imaging show?
• What are the signs that another vascular event has occurred — and when should we seek emergency care?
• Are there specialist referrals (cardiologist, vascular neurologist) that would add value here?

---

Lewy body dementia

What it is and why it's frequently misdiagnosed

Lewy body dementia (LBD) is the third most common type and, in many ways, the most important for families to understand in detail. It is consistently underdiagnosed — many people spend years being treated for Alzheimer's, Parkinson's disease, or psychiatric conditions before the correct diagnosis is established.

LBD is caused by deposits of a protein called alpha-synuclein (Lewy bodies) in the brain. It overlaps with Parkinson's disease in its underlying biology, and in fact Parkinson's disease dementia and Lewy body dementia are considered related conditions on the same spectrum.

The cognitive symptoms of LBD are often more fluctuating than Alzheimer's — a person may seem nearly like themselves one hour and profoundly confused the next. This fluctuation is a diagnostic clue and a practical challenge for families who may feel like something is inconsistent or exaggerated.

Hallucinations that are part of the disease

One of the defining features of Lewy body dementia is vivid, recurrent visual hallucinations — often of people or animals — that are typically detailed and non-threatening. These are not psychiatric hallucinations. They are a direct symptom of the disease's effect on the visual processing areas of the brain.

This distinction matters because families often rush to the ER or push for psychiatric medication when hallucinations appear, not knowing they are part of the condition. In many cases, the hallucinations are more distressing to the family than to the person experiencing them. The appropriate response is usually not aggressive treatment, but calm reassurance and careful observation — and a conversation with the neurologist about whether the hallucinations are causing distress or functional problems.

Medication sensitivity: a genuine safety issue

This is the section to read carefully.

People with Lewy body dementia can have severe, life-threatening reactions to certain antipsychotic medications. These are drugs that are sometimes prescribed to manage agitation, psychosis, or behavioral symptoms in dementia. In people with LBD, even small doses of older antipsychotics (like haloperidol, fluphenazine, or thioridazine) can cause a reaction called neuroleptic sensitivity, which includes sudden and severe worsening of movement symptoms, extreme rigidity, confusion, high fever, and in some cases death.

Even some newer antipsychotics carry risk in LBD and should only be used with extreme caution under specialist guidance.

What this means practically:

• Every healthcare provider your parent sees — including ER staff, hospitalists, and on-call doctors — needs to know about the Lewy body diagnosis and this medication risk, every time
• This should be documented on any medical ID, on the summary sheet you carry to appointments, and communicated verbally at every admission or urgent care visit
• If a doctor suggests an antipsychotic for behavioral management, ask specifically: "Is this safe for Lewy body dementia?" before it is administered

The Lewy Body Dementia Association (LBDA) publishes a downloadable emergency medical alert card for exactly this purpose. Keeping one in the person's wallet and in the medical binder is not excessive — it is appropriate preparation.

What's different about care

Because LBD overlaps with Parkinson's, motor symptoms (shuffling gait, muscle stiffness, falls) are often part of the picture and may require physical therapy and fall prevention planning that isn't as central in Alzheimer's care.

Sleep disturbances are also common and can be significant — specifically, REM sleep behavior disorder (acting out dreams, sometimes violently), which can predate the dementia diagnosis by years. This affects both the person and any bed partner, and is something the care team should know about.

Questions to ask the neurologist

• Are there any medications currently prescribed — or commonly prescribed — that we should avoid given this diagnosis?
• What should we do if hallucinations become distressing or frequent?
• Is a DaTscan or other imaging available to confirm the diagnosis?
• Should we connect with a movement disorder specialist given the Parkinson's overlap?
• What is the safest approach for managing agitation or behavior changes if they occur?

---

Frontotemporal dementia (FTD)

What it is and who it affects

Frontotemporal dementia is different from the other three types in a way that often catches families completely off guard: it frequently affects people in their 50s and early 60s, well before the age most people associate with dementia. It is one of the most common causes of dementia in people under 65.

FTD involves progressive degeneration of the frontal and temporal lobes — the regions that govern personality, social judgment, language, and behavior. There are several variants, but the most common presents with personality and behavior changes rather than memory loss.

What it looks like

Because FTD often begins with behavior changes rather than memory loss, it is frequently misdiagnosed as depression, bipolar disorder, a midlife crisis, or a personality change with no medical explanation. Common early signs include:

• Loss of empathy or emotional warmth toward people who were previously close
• Disinhibition — saying or doing things that are socially inappropriate
• Apathy and loss of motivation
• Repetitive or compulsive behaviors
• Impulsive decision-making, including financial decisions
• Changes in food preferences, often toward sweets or carbohydrates

Memory is often relatively preserved in early FTD, which is part of why the diagnosis is missed. The person may seem "changed" or "difficult" rather than cognitively impaired.

What's different about care

FTD care has a different emotional texture than Alzheimer's care. Because the person affected is often younger, there are often employment, insurance, and financial considerations that older-onset dementia may not trigger in the same way. There may be dependent children still at home. A partner or spouse may be simultaneously the primary caregiver and dealing with their own career and financial pressures.

Behaviorally, the disinhibition and lack of empathy that characterize FTD can be far more straining on family relationships than memory loss. It is important for families to understand that these are not personality choices — they are symptoms of the disease. Caregiver support and counseling are not optional extras in FTD families; they are often essential to preventing caregiver collapse.

Standard Alzheimer's medications (cholinesterase inhibitors) are generally not effective for FTD and in some cases may worsen behavior. Treatment focuses on symptom management and supportive care.

FTD also has a stronger genetic component than Alzheimer's in some forms, which may be relevant for adult children to discuss with a genetic counselor.

Questions to ask the neurologist

• Which variant of FTD is this — behavioral variant, primary progressive aphasia, or another?
• Are the current Alzheimer's medications appropriate to continue, or should we discuss stopping them?
• Is genetic testing something the family should consider given the younger onset?
• Are there specialized FTD clinics or support groups — the AFTD (Association for Frontotemporal Degeneration) is a good resource to ask about?
• What behavioral symptoms should we prepare to manage, and what approaches work best?

---

Questions to ask the neurologist after any dementia diagnosis

Regardless of type, these questions apply after a new diagnosis and can help your family come out of appointments with more clarity:

1. What is the specific type of dementia, and how confident are you in the diagnosis?
2. What does a typical progression look like for this type, and over what timeframe?
3. Are there medications that are currently approved or appropriate for this diagnosis?
4. Are there any medications we are currently using that we should reconsider?
5. What are the safety priorities we should be planning for now?
6. What kind of specialist follow-up makes sense — memory clinic, behavioral neurologist, movement disorder specialist?
7. Is neuropsychological testing appropriate to establish a clearer baseline?
8. What should we watch for that would indicate the disease is progressing faster than expected?

Writing questions down before the appointment and bringing someone to take notes — or asking to record the conversation — are not unusual requests. Neurologists who specialize in dementia expect families to have questions.

---

What to do if the diagnosis feels uncertain

Dementia diagnoses, particularly in earlier stages or for less common types like Lewy body and FTD, are not always straightforward. If the diagnosis feels uncertain — or if you were given a general "dementia" label without a specific type — asking for further evaluation is appropriate and common.

Options for more specific workup include:

• Neuropsychological testing: a multi-hour battery of cognitive tests that creates a detailed map of which functions are preserved and which are affected; helps distinguish between types
• Advanced imaging: FDG-PET or amyloid-PET scans can identify Alzheimer's pathology; DaTscan imaging is used to evaluate Parkinson's-related dopamine deficiency relevant to Lewy body dementia
• Cerebrospinal fluid (CSF) biomarkers: a lumbar puncture can detect amyloid and tau proteins associated with Alzheimer's
• Referral to a memory clinic or academic medical center: often the most efficient path to a clearer answer, especially for younger-onset cases

A second opinion from a behavioral neurologist or geriatric psychiatrist is always appropriate. Getting a clear diagnosis is worth the time — not because it changes what your parent is going through emotionally, but because it allows the care team to make better decisions and helps your family plan with more accuracy.

---

The goal in all of this is not to become an expert in neurology. It is to be a more informed partner in your parent's care — someone who understands enough to ask better questions, catch potential problems, and plan for what is likely coming rather than being caught off guard by it. The type of dementia matters, and knowing what you're dealing with is the beginning of that partnership.

For further reading, the Alzheimer's Association provides a detailed overview of dementia types and causes. If your parent has been diagnosed with or is being evaluated for Lewy body dementia specifically, the Lewy Body Dementia Association is one of the most useful resources available — including their medication safety guidance, which is worth bringing to every medical appointment.